Charles Schwab’s SBC Medical Group SBC Stock Holding History
Bought
Maintained
Sold
Other funds holding SBC
VCM
SBH
VPM
VFT
SS
Charles Schwab's SBC Position: Q1 2026 in Review
Charles Schwab reduced its SBC Medical Group (SBC) stake by 33% in Q1 2026, selling an estimated $38.1K and leaving 18,201 shares worth $76.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3405.
Charles Schwab first reported a position in SBC in Q2 2025 and has held it in 4 quarters since. The position peaked at $118K in Q4 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.
- Charles Schwab held 18,201 shares of SBC Medical Group worth $76.1K as of Q1 2026.
- Charles Schwab sold 9,140 SBC Medical Group shares in Q1 2026, an estimated $38.1K.
- SBC Medical Group made up ﹤0.01% of Charles Schwab's portfolio in Q1 2026, its #3405 holding.
- Charles Schwab first reported a position in SBC Medical Group in Q2 2025 and has held it in 4 quarters since.
- Charles Schwab's SBC Medical Group position peaked at $118K in Q4 2025.
- 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.